LONDON, Jan 20, 2020 (GLOBE NEWSWIRE via COMTEX) — LONDON, Jan. 20, 2020 (GLOBE NEWSWIRE) — Hutchison China MediTech Limited (“Chi-Med”) (aim/nasdaq:HCM) today announces that the independent Data Monitoring Committee (“IDMC”) of the...
Fasenra being evaluated in eight eosinophil-driven diseases beyond severe asthma AstraZeneca today announced three new trials for Fasenra (benralizumab) in skin diseases, adding to five trials already underway for the medicine in eosinophil-driven diseases (EDDs)...
Surge of Research Organizations Investing in Florence Shows New Wave of Site Leadership in Streamlining Study Operations ATLANTA – January 16, 2020 – (Newswire.com) Florence, an Atlanta-based clinical trial software company, today announces that it doubled...
WAKEFIELD, Mass., Jan. 16, 2020 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, is pleased to inform shareholders that the Company has dosed the first cohort in its Phase 1 trial to...
Kala Pharmaceuticals has completed enrollment in the STRIDE 3 trial for KPI-121 0.25%, a treatment for temporary dry eye relief, according to a press release. The enrollment follows a previous new drug application rejection from the FDA, which said that efficacy data...
Email
Text